Kevin Dukes, MD
Sports Medicine · Tulsa, OKNPI 1710955901
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (43.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Pylant Medical at 56.6% of the total. Reporting peaked in 2022 at $2,973 and has fallen 94.0% since, to $177 in 2025.
Across 111 payments — averaging $74.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$5K
- Zimmer Biomet$2K
- Sanofi-aventis U.S. LLC$350
- Pacira Therapeutics, Inc.$307
- Johnson & Johnson$174
- Bioventus LLC$149
- plus $581 from 11 others
What the payments were for
- Speaking & faculty fees$801%
- Travel & lodging$1,08213%
- Food & beverage$3,55043%
- Education$3,55243%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 31 | $4,680 |
| Zimmer Biomet | 15 | $2,024 |
| Sanofi-aventis U.S. LLC | 14 | $350 |
| Pacira Therapeutics, Inc. | 15 | $307 |
| Johnson & Johnson(2 entities) | 6 | $174 |
| Bioventus LLC | 8 | $149 |
| Aesculap Biologics, LLC | 2 | $117 |
| Pacira Pharmaceuticals Incorporated | 4 | $92 |
| Exactech, Inc. | 2 | $91 |
| Amgen | 4 | $75 |
| Ferring Pharmaceuticals Inc. | 3 | $42 |
| Stryker | 1 | $36 |
| Zyla Life Sciences, Inc. | 2 | $31 |
| Vertex | 1 | $28 |
| Davol Inc. | 1 | $27 |
| P Bar Medical LLC | 1 | $24 |
| Deroyal Industries, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,265 in reported general payments places this provider in the 85th percentile of 55 sports medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 174 | $1,888 |
| Meloxicam | 111 | $548 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 47 | $388 |
| Cephalexin | 72 | $277 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $209 |
| Gabapentin | 24 | $111 |
| Cyclobenzaprine Hcl | 15 | $93 |
| Tramadol Hcl | 15 | $52 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $34 |
| Amoxicillin | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Tulsa
- Antoine JabbourTulsa$55K
- Chad HansonTulsa$40K
- Jason GriffinTulsa$17K
- Gwendolyn EmersonTulsa$13K
- Andrew EbertTulsa$11K
- Jacob WorshamTulsa$7K
- John BalbasTulsa$5K
- Barry DockeryTulsa$3K
- Keith StanleyTulsa$1K
- Donald BarneyTulsa$928
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.